Search Results
298 items found for "Keywords: B cell migration"
- 📰 GPCR Weekly News, May 27 to June 2, 2024
pathway GPCR Screening Reveals that the Metabolite Receptor HCAR3 Regulates Epithelial Proliferation, Migration regulates the expression and alternative splicing of genes associated with aphasia-related diseases in PC12 cells Scientist Senior Research Associate/Associate Scientist, Protein Science Post-Doctoral Fellow—Pharmacology/Cell
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Gunnar Schulte et al. on the study of the interaction of Clostridioides difficile toxin B and FZD7. the Classified GPCR News from January 29th to February 4th, 2024 Adhesion GPCRs CELSR1, a core planar cell development Structural and functional insight into the interaction of Clostridioides difficile toxin B
- 📰 GPCR Weekly News, March 20 to 26, 2023
disease GPCRs in Oncology and Immunology Purinergic GPCR-integrin interactions drive pancreatic cancer cell CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes. Evidence that RXFP4 is located in enterochromaffin cells and can regulate production and release of serotonin Call for GPCR Papers GPCRs: Signal Transduction. Ends tomorrow - March 31st, 2023. NEW FREE Symposium - IPI Surfacing (June 15, 2023) Training School on “Cell-based assays to study Adhesion
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
determine the functional consequences of every possible amino acid change at each position in a protein, as well J., Shoichet, B. K., & Jacobson, K. A. (2010). B., Chang, B., & Peisajovich, S. G. (2017). M., Marti-Solano, M., Sandhu, M., Kobilka, B. K., Bouvier, M., & Babu, M. M. (2023).
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
We selected the adenosine receptor 2B (A2BAR), specifically expressed in cancer cell lines compared with stromal cells, to explore the use of fluorescent ligands that can be used for target visualization. Fluorescent probes allowed semi-quantitative receptor mapping in living cells and validated the specific expression of A2BAR in CRC cell lines. a potential pharmacological tool in CRC, using selective antagonists, finding a reduction in tumor cell
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
as in human melanoma cells either expressing (A7) or lacking (M2) FLNA. First, we observed the formation of endogenous SST5 homo-dimers in GH3, A7, and M2 cells. SST2 and SST5 can also form endogenous hetero-dimers in these cells. robust receptor internalization at shorter times than in A7 cells. In conclusion, we demonstrated that in GH3 cells SST2 and SST5 can form both homo- and hetero-dimers
- C3aR plays both sides in regulating resistance to bacterial infections
product of C3 cleavage, which interacts with membrane-bound receptor C3aR to regulate innate immune cell Specifically, previous research has identified mechanistically distinct and cell type–specific roles for C3aR in regulating innate immune cell inflammatory state, antimicrobial killing capacity, and metabolism of C3a has been relegated to the serum; however, recent studies have provided evidence that various cell Thus, this review will cover specific roles of C3aR in driving cell type–specific and tissue specific
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
TM5 on one hand, and TM1 and TM7 on the other hand, form possible dimerization interfaces (Ploier, B. Li, et al 2012; B. Bai, et al. 2014; B. Ji, et al. 2020; L. Wan, 2020). heterodimers with other members of the class A GPCR family such as with bradykinin 1 and 2 receptors (B. Bai et al. 2014; B. Ji et al., 2020).
- A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in...
2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology in Cell Membranes and Living Cells "Conformational biosensors to monitor the activation state of G protein-coupled (H3R) biosensor that allowed the detection of both (partial) agonism and inverse agonism on living cells In the current study, we have further characterized this H3R biosensor on intact cells by monitoring binding assays that in addition can also detect ligand efficacies with comparable values as the intact cell
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
of several hundred candidate hits, enriched because they either bind with increased affinity at the cell Figure 4: Payload delivery using Orion’s superagonist analogs on target cells expressing CCR5. at killing cells than unconjugated MMAE, the Orion CCL5 superagonist analog significantly increased both the potency and selectivity of the payload towards target cells. Figure 5: In an in vitro functional signaling assay on a human monocytic cell line, OB-004 demonstrated
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
September 2022 "Sound is converted by hair cells in the cochlea into electrical signals, which are transmitted Frizzleds and Lgrs are dominant GPCRs that regulate stem cell self-renew abilities. Frizzleds and Celsrs have been demonstrated to play core roles in the modulation of cochlear planar cell review the key findings of GPCR in the cochlea and discuss the role of GPCR in the cochlea, such as stem cell
- New role of β-arrestins in MOR signaling
compartments and their activation is generally related to inhibiting neurotransmission by hyperpolarizing the cell signaling, Shiraki et al., explored the function of β-arrestin 2 in MOR signaling using the SH-SY5Y cell Reeves KC, Shah N, Muñoz B, Atwood BK.
- 📰 GPCR Weekly News, April 24 to 30, 2023
Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells. Bioorthogonal Tethering Enhances Drug Fragment Affinity for G Protein-Coupled Receptors in Live Cells Single-cell transcriptome analysis of NEUROG3+ cells during pancreatic endocrine differentiation with Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney FREE Symposium - IPI Surfacing (June 15, 2023) Training School on “Cell-based assays to study Adhesion
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
chemokine receptors, mainly activated by interleukin 8 (IL-8 or CXCL8), are expressed in a variety of cells including, leukocytes, fibroblasts, endothelial cells, and smooth muscle cells. of the ligand, its concentration, and the binding sites with the receptor, levels of the receptor, cell
- GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis
GPR110 belongs to adhesion GPCR and was the functional receptor of N-docosahexaenoyl ethanolamine (also called Synaptamide suppressed osteoclastogenesis induced by receptor activator of nuclear factor-kappa B ligand
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
chemokine receptors, mainly activated by interleukin 8 (IL-8 or CXCL8), are expressed in a variety of cells including, leukocytes, fibroblasts, endothelial cells, and smooth muscle cells. of the ligand, its concentration, and the binding sites with the receptor, levels of the receptor, cell
- Novel interaction between neurotrophic factor-α1/carboxypeptidase E and serotonin receptor, 5-HTR1E,
CPE-binding studies demonstrated saturable, high-affinity binding to 5-HTR1E in stably transfected HEK293 cells Treatment of 5-HTR1E stable cells with NF-α1/CPE increased pERK 1/2 and pCREB levels which prevented Cell survival assay in β-arrestin Knockout HEK293 cells showed that the NF-α1/CPE-5-HTR1E-mediated protection Immunofluorescence studies showed 5-HTR1E and NF-α1/CPE are highly expressed and co-localized on cell CPE-mediated protection of these neurons against oxidative stress and glutamate neurotoxicity-induced cell
- 📰 GPCR Weekly News, June 17 to 23, 2024
for disease therapy GPCRs in Cardiology, Endocrinology, and Taste Transcriptomic profiling highlights cell Metallo-protease Peptidase M84 from Bacillusaltitudinis induces ROS-dependent apoptosis in ovarian cancer cells of the nematode-trapping fungus Arthrobotrys flagrans activates mitochondria and reprograms fungal cells Deuteration as a General Strategy to Enhance Azobenzene-Based Photopharmacology Optical Control of Cell-Surface Scientist Senior Research Associate/Associate Scientist, Protein Science Post-Doctoral Fellow—Pharmacology/Cell
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCRs in Oncology and Immunology A2aR on lung adenocarcinoma cells: A novel target for cancer therapy Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration 15, 2023) GPCRs in drug discovery: challenges & solutions (June 19 - 23, 2023) Training School on “Cell-based
- 📰 GPCR Weekly News, September 18 to 24, 2023
Cardiology, Endocrinology, and Taste Structural and functional analysis of salivary intercalated duct cells reveals a secretory phenotype Mesenchymal stromal cell secretory molecules improve the functional survival pathway by G protein-coupled receptor 37 promotes resistance to cisplatin-induced apoptosis in non-small cell Program Receives €4 Million Grant Confo Therapeutics Appoints Stephen Dowd As Chief Business Officer Call Technician Senior Research Associate, In Vitro Pharmacology - Crinetics Pharmaceuticals Postdoc In Cell
- Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin ...
Stimulation of AVPR2 with a selective agonist desmopressin promoted CRPC cell proliferation through cAMP In contrast, blocking AVPR2 with a selective FDA-approved antagonist, tolvaptan, reduced cell growth. Combinatorial use of AVPR1A and AVPR2 antagonists promoted apoptosis synergistically in CRPC cells. Furthermore, we found that castration-resistant cells produced AVP, the endogenous ligand for arginine vasopressin receptors, and knockout of AVP in CRPC cells significantly reduced proliferation suggesting
- 📰 GPCR Weekly News, May 20 to 26, 2024
Oncology and Immunology Enterococcus-derived tyramine hijacks α2A-adrenergic receptor in intestinal stem cells to exacerbate colitis The EBI2 receptor is coexpressed with CCR5 in CD4+ T cells and boosts HIV-1 R5 laboratory and point-of-use settings Quantitative proteomics reveals CLR interactome in primary human cells Exploiting Cell-Based Assays to Accelerate Drug Development for G Protein-Coupled Receptors TOR signaling Scientist Senior Research Associate/Associate Scientist, Protein Science Post-Doctoral Fellow—Pharmacology/Cell
- Decoding β-Arrestins: from Structure to function
activate specific G protein families, others are more versatile, yielding diverse responses based on cell-specific Recently, Maharana et al. determined multiple structures of activated b-arrestins in complex with the using cryo-EM, and discovered a significantly conserved phosphorylation motif in GPCRs that drives b-arrestin This includes proteins like AP-2 and clathrin, vital for internalization, as well as MAPK cascade kinases signaling pathways governed by β-arrestins, which exhibit increased or reduced activity within distinct cell
- 📰 GPCR Weekly News, February 19 to 25, 2024
GPR3 After wounding, a G-protein coupled receptor promotes the restoration of tension in epithelial cells dynamics in aPVT glutamatergic neurons GPCRs in Oncology and Immunology TIPE proteins control directed migration of human T cells by directing GPCR and lipid second messenger signaling Methods & Updates in GPCR Research
- Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and ...
Information exchange and interpretation is essential in biology and understanding how cells integrate of information-coding molecules into complex orchestrated responses is a major challenge for modern cell In complex organisms, cell to cell communication occurs mostly through neurotransmitters and hormones are responsible for signal recognition at the membrane level and information transduction inside the cell the formation of GPCRs higher order oligomers provides the structural basis for organizing distinct cell
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
The sheer complexity of the cell and the astonishing diversity of diseases are just two reasons why researchers For example, chemotherapy, a powerful standard approach to kill fast-growing cancer cells, has the drawback of causing damage to healthy cells in the process, leading to side effects that can include pain, nausea drug development approaches include a range of techniques leveraging structural biology, immunology, cell
- Chemokine receptor-targeted drug discovery: progress and challenges
for the treatment of mycosis fungoides or Sézary syndrome in adults which are subtypes of cutaneous T-cell Redundancy can be exemplified by the tumor infiltration of Treg cells which can be driven directly by different chemokines are able to activate different pathways, which can also vary depending on the cell CCR3 and CCR5, and induces different patterns of receptor recycling where CCR5 recycles back to the cell surface (Mack et al. 1998), CCR3 is partially restored to the cell surface and partially targeted to
- 📰 GPCR Weekly News, October 16 to 22, 2023
Sakmar and his team used 'bioluminescence resonance energy transfer to measure cell-surface expression of neurodegenerative diseases GPCRs in Neuroscience Primary cilia control oligodendrocyte precursor cell disease for novel drug discovery Application of bioluminescence resonance energy transfer to quantitate cell-surface Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ESMO 2023 Restoring the function of a human cell surface protein in yeast cells Trevena Reports Favorable TRV045 Topline Safety and Tolerability Data